Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-attributed anaphylaxis.

D Y Wang1, C Forslund, U Persson

  • 1Shanghai Medical University, Hua Shan Hospital, China.

Pharmacoepidemiology and Drug Safety
|April 10, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[<i>In vitro</i> study of non-thermal atmospheric plasma influencing the surface properties of dentin].

Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology·2021
Same author

Genetic variations in gamma-secretase and PSTPIP1 in hidradenitis suppurativa in Singaporean Chinese.

Journal of the European Academy of Dermatology and Venereology : JEADV·2021
Same author

Improved Performance of All-Solid-State Flexible Supercapacitor Based on the Stress-Compensation Effect.

Journal of nanoscience and nanotechnology·2021
Same author

[Novel coronavirus infection prevention and control measures in occupation health examination].

Zhonghua lao dong wei sheng zhi ye bing za zhi = Zhonghua laodong weisheng zhiyebing zazhi = Chinese journal of industrial hygiene and occupational diseases·2020
Same author

[Effect of fluid resuscitation guided by pulse contour cardiac output monitoring technology on organ function in extremely severe burn patients].

Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns·2020
Same author

Observation of the Doubly Cabibbo-Suppressed Decay D^{+}→K^{+}π^{+}π^{-}π^{0} and Evidence for D^{+}→K^{+}ω.

Physical review letters·2020

Drug-induced anaphylaxis is a serious concern, with 3.8% of reported cases being fatal. Preventive measures like dextran 1 and non-ionic contrast media have significantly reduced risks, highlighting the importance of ongoing surveillance.

Area of Science:

  • Pharmacovigilance
  • Clinical Toxicology
  • Immunology

Background:

  • Allergic type I reactions to medications present a spectrum from mild symptoms to life-threatening anaphylaxis.
  • Drug-induced anaphylaxis poses a significant public health challenge, necessitating robust monitoring systems.

Purpose of the Study:

  • To analyze patient characteristics and suspected drugs involved in anaphylactic reactions and shock reported in Sweden between 1972 and 1995.
  • To evaluate the impact of specific interventions on the incidence of drug-induced anaphylaxis.

Main Methods:

  • Retrospective analysis of 1338 case reports of suspected drug-induced anaphylaxis/shock from Sweden (1972-1995).
  • Comparison of reporting rates for different drugs (dextrans, X-ray contrast media, antibiotics) before and after specific interventions.

Related Experiment Videos

  • Inclusion of drug sales and prescription data for comparative analysis.

    • Main Results:

    • An overall reporting rate of seven cases per million inhabitants per year for drug-induced anaphylaxis was observed.
    • Dextran use showed a significant decrease in anaphylactic reactions, shock, and fatalities after the introduction of preventive treatment with dextran 1 in 1983.
    • Non-ionic contrast media were associated with lower reaction rates and no fatal cases compared to ionic contrast media.
    • Benzylpenicillin had a higher reported rate of anaphylaxis than phenoxymethylpenicillin.

    Conclusions:

    • Spontaneous reporting systems are crucial for identifying drug-induced anaphylaxis risks.
    • Interventions such as preventive treatments and shifts to safer drug formulations (e.g., non-ionic contrast media) can effectively mitigate anaphylaxis risks.
    • Continued surveillance and the development of quantitative methods are essential for improving drug safety.